# Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque

> **NCT00408382** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 50 (—)

## Conditions studied

- Hypercholesteremia
- Coronary Artery Disease

## Interventions

- **DRUG:** atorvastatin, Lipitor

## Key facts

- **NCT ID:** NCT00408382
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (—)
- **Last updated:** 2011-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00408382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00408382, "Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00408382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*